Biotech, Biosciences and Biopharmaceutical Companies in New York
Acorda Therapeutics, Hawthorne,NY:A privately-held biotechnology company, is developing therapies for spinal cord injury (SCI), multiple sclerosis (MS) and related nervous system disorders. Acorda’s lead clinical-stage product is Fampridine-SR, which is being developed for both MS and SCI. The Company’s pipeline includes a number of products in development for the treatment, regeneration and repair of the spinal cord and brain.

Advanced BioHealing, NY, NY:An industry leader in the science of regenerative medicine. The Company is focused on the commercialization of cell-based and tissue-engineered products including two that have FDA approval for marketing: Dermagraft, for diabetic foot ulcers and TransCyte, to treat full and partial thickness burns. The company’s development pipeline includes a next-generation bioengineered tissue product which is in clinical trials. ABH is a privately held company with research & development offices in New York, NY and manufacturing operations in La Jolla, CA.

Advanced Viral Research, Yonkers, NY:A biopharmaceutical firm dedicated to improving patients' lives by researching, developing, and bringing to market new and effective therapies for many serious diseases and disorders. ADVR is aggressively working to bring its flagship product, AVR118, to patients. A real blockbuster potential exists for this new type of biopolymer chemistry, which possesses novel immunomodulator activity. This peptide-nucleic acid complex, which to date has demonstrated a very favorable safety profile, appears to stimulate the pro-inflammatory response required to combat viral infections, such as HIV; and to dampen aberrant autoimmune-type inflammatory responses, which often occur in diseases such as rheumatoid arthritis.

Advion, Ithaca, NY:Provides bioanalytical contract services to the pharmaceutical industry. Spurred by the growing demand for MS and lab-on-a-chip technologies in life-sciences research and drug discovery, the company expanded its vision and focus, providing bioanalytical services and nanoelectrospray products.

AGI Dermatics, Freeport, NY:Foucesed on skin photobiology -- the study of biological effects of sunlight on skin. Within this field, AGI Dermatics is researching DNA repair, solar impact on the immune system, photoaging, tanning and cell-signaling in skin.

Albany Molecular Research, Inc., Albany, NY: Service and Drug Discovery company. chemistry-based drug discovery, development and manufacturing company, focusing on small molecule prescription drugs.

Angiotech Pharmaceuticals, Henrieta, NY:A specialty pharmaceutical company pioneering the combination of pharmaceutical compounds with medical devices and biomaterials to both create novel solutions for poorly addressed disease states and dramatically improve surgical outcomes.
 
Antigenics Inc., NY, NY:A biotechnology company working to develop personalized immunotherapeutics and revolutionary treatments for cancers and infectious diseases. The Company’s lead product candidate is a late-stage, personalized cancer vaccine being evaluated in several indications, including renal cell carcinoma and metastatic melanoma. Antigenics’ portfolio of investigational products also includes a personalized cancer vaccine in Phase 2 development; two liposomal cancer treatments; and a genital herpes program.

Aureon  Biosciences Corporation, Yonkers, NY:A CLIA-certified diagnostic laboratory that develops and provides predictive testing for personalized cancer clinical care as well as for the pharmaceutical R&D industry. Predictive testing simultaneously takes into account the clinical, micro-anatomic, and molecular aspects of disease, enabling the development of advanced diagnostics and therapeutics. Aureon’s first clinical test will be in the area of prostate cancer, the most commonly diagnosed non-skin cancer in the United States. Aureon is also working on initiatives in the areas of breast, lung, and colon cancers.

Bayer Corporation, Diagnostic Division, Tarrytown, NY:Part of the worldwide Bayer Group, an international health care, nutrition and innovative materials group based in Leverkusen, Germany. Bayer employs 23,300 in North America with net North American sales of 8.8 billion euros in 2003. Bayer's three operating business areas - HealthCare, CropScience and MaterialScience, produce a broad range of products that help diagnose and treat diseases, protect crops, advance automobile safety and durability and improve people's lives.

Barr Pharmaceutical, Inc., Pomona, NY: Developing, manufacturing and marketing quality generic and proprietary pharmaceuticals in specific therapeutic categories.

Bio Balance, Inc., NY, NY:Devoted to a biophysical description of the initial receptor response. From this research, Bio Balance has developed the proprietary technology to prevent receptor desensitization, which is also known as tachyphylaxis, down-regulation, tolerance or fade. This should lead to improved pharmaceuticals and be an attractive and alternative route to drug development in the future.

BioSpecifics Technologies, Lynbrook, NY: A biopharmaceutical company with a focus on wound healing and tissue remodeling. It has pioneered the application of collagenase for several disease conditions, notably dermal ulcers, pressure sores (bedsores), and second and third degree burns. BioSpecifics produces Collagenase ABC, the essential ingredient in the prescription drug Collagenase Santyl® Ointment sold in the United States, and under other trademarks abroad. Collagenase Santyl® Ointment is distributed in North America by Smith & Nephew.

BrainStorm Cell Therapeutics Inc., New York NY:Biotech, Cell Therapeutics, Neuroscience, stem cell technologies, neurodegenerative diseases, Parkinson's Disease, Amyotrophic Lateral Sclerosis and Multiple Sclerosis.

Breonics, Inc., Schenectady, NY:A biomedical research and development company headquartered in Otisville Technology Park, Orange County, New York. Breonics' focus is to apply its novel bioengineering technologies to create innovative medical products for the clinical organ transplant and tissue replacement markets. The Company's primary strategy is to capitalize on its technologies by developing them to product definition and to then collaborate with a strategic partner who has the expertise and resources for rapid commercial introduction.

Cara Therapeutics Inc., Tarrytown, New York: Biotech, Biopharmaceuticals, developing novel therapeutics to treat human diseases associated with pain and inflammation.

Chembio Diagnostics, Medford, NY:Develops and manufactures rapid tests to aid in the detection of infectious diseases including HIV and Tuberculosis (TB). Using lateral flow technology, these rapid tests easily provide users with quick and cost-effective information simply by applying sample material to a test strip that has been treated with specific agents in order to help detect the presence of the infectious disease or antibodies to such disease in that sample.

Celltech, Rochester, NY:A publicly traded bioharmaceutical company with headquarters in Brussels, Belgium, specialising in the fields of central nervous system disorders, allergy and respiratory diseases, immune and inflammatory disorders and oncology.

Curative Health Services, Hauppauge, NY:Seeks to deliver high-quality care and clinical results for patients with serious or chronic medical conditions. The Specialty Infusion business, through its national footprint of local pharmacy branches, provides products, related clinical services and disease management support to patients with chronic or severe conditions such as hemophilia and other bleeding disorders, chronic or severe infections, gastrointestinal illnesses that prohibit oral digestion and other severe conditions requiring nutritional support, immune system disorders, cancer and susceptibility to respiratory syncytial virus.

Cytopia (formerly Myomatrix Therapies Inc.), NY, NY:A Melbourne-based drug discovery and development company committed to redefining the way medicines are discovered It's vision is to discover and develop a new generation of therapeutic drugs for cancer and immune disease. Already, Cytopia has applied its medicinal chemistry capability, high-throughput screening facility and computational chemistry platform to develop a broad pipeline of novel pre-clinical drug candidates.

Direct Therapeutics, White Plains, NY:A development-stage pharmaceutical company using its patented Solvent-Facilitated Perfusion technology to create new drugs for the localized and regional treatment of solid-tumor cancers. Itsproducts are designed for direct injection to target tissue with minimal invasion of healthy tissue. They contain active ingredients in organic solvent vehicles that facilitate the penetration of the drug throughout tumor tissue and into tumor cells. In contrast to "sustained release" or "controlled release" products, our products rapidly, selectively, and thoroughly saturate tumors with doses of potent chemotherapeutic agents unachievable by other means. We have demonstrated that these products, when directly applied by needle or catheter to solid tumors, perfuse preferentially throughout the tumor, leading to rapid, selective death of cancerous tissue.

deCODE genetics, Communications and Investors Relation.  NY, NY:  develop and commercialize new drugs to treat and prevent common diseases,  Heart attack (also called myocardial infarction, Asthma, type 2 diabetes, Schizophrenia , Obesity

E-Z-EM, Lake Success, NY:A recognized leader in imaging of the gastrointestinal tract. From the first disposable barium enema administration kit the company introduced in 1962, to today’s advanced CT and virtual colonoscopy products, E-Z-EM has continued to developed innovative imaging solutions.
Today, its business encompasses CT imaging, Virtual Colonoscopy, Speech Pathology, Gastro devices and accessories, and defense decontaminants.

Egenix, Inc., Mill Brooks, NY:A privately held biotechnology company in the business of developing diagnostic and therapeutic products for cancer patients. Its corporate headquarters are in Millbrook, New York, and its research laboratory is located at the University of Rochester Medical Center in Rochester, New York.

Emisphere Technologies, Tarrytown, NY:A biopharmaceutical company pioneering the oral delivery of otherwise injectable drugs. Emisphere's business strategy is to develop oral forms of injectable drugs, either alone or with corporate partners, by applying its proprietary eligen(R) technology to those drugs or licensing its eligen(R) technology to partners who typically apply it directly to their marketed drugs. Emisphere's eligen(R) technology has enabled the oral delivery of proteins, peptides, macromolecules and charged organics. Emisphere and its partners have advanced oral formulations or prototypes of salmon calcitonin, heparin, insulin, parathyroid hormone, human growth hormone and cromolyn sodium into clinical trials. Emisphere has strategic alliances with world-leading pharmaceutical companies.

Enzo Biochem Inc., NY, NY:Engaged in the research, development and manufacture of innovative health care products based on molecular biology and genetic engineering techniques, and in providing diagnostic services to the medical community. The Company’s proprietary labeling and detection products for gene sequencing and genetic analysis are sold to the life sciences market throughout the world. The Company’s therapeutic division is in various stages of clinical evaluation of its proprietary gene medicine for HIV-1 infection and its proprietary immune regulation medicines for hepatitis B and hepatitis C infection and for Crohn’s Disease.

Eyetech Pharmaceuticals Inc., NY, NY:A biopharmaceutical company that specializes in the development and commercialization of novel therapeutics to treat diseases of the eye. Its initial focus is on diseases affecting the back of the eye, particularly the retina.

Ferring Pharmaceuticals, Suffern, NY:Part of the Ferring Group, a privately owned, international pharmaceutical company, markets menotropins, urofollitropin, purified menotropins, and chorionic gonadotropin for injection, in the U.S. to infertility specialists and their patients. Ferring also offers the first needle-free reconstitution device, for use with its fertility treatments. The Ferring Group specializes in the research, development and commercialization of compounds in general and pediatric endocrinology, urology, gastroenterology, obstetrics/gynecology and infertility.

Forest Laboratories, NY, NY:Growing line of products includes: Lexapro(R) (escitalopram oxalate), an SSRI antidepressant indicated for the initial and maintenance treatment of major depressive disorder and for generalized anxiety disorder in adults; Namenda(R) (memantine HCl), an N-methyl-D-aspartate (NMDA)-receptor antagonist indicated for the treatment of moderate to severe Alzheimer's disease; Benicar(R) * (olmesartan medoxomil), an angiotensin receptor blocker indicated for the treatment of hypertension; Benicar* HCT(R) (olmesartan medoxomil hydrochlorothiazide), an angiotensin receptor blocker and diuretic combination product indicated for the second-line treatment of hypertension; Campral(R) * (acamprosate calcium), a glutamate receptor modulator, indicated for the maintenance of abstinence from alcohol in patients with alcohol dependence who are abstinent at treatment initiation in combination with psychosocial support; and Combunox(TM) (Oxycodone HCl and Ibuprofen), an opioid and NSAID combination indicated for the short-term management of acute, moderate to severe pain.

GE Global Research,  Niskayuna, NY: One of the world's most diversified industrial research organizations, providing innovative technology for all of GE’s businesses. Global Research has been the cornerstone of GE technology for more than 100 years, and is now focused on developing breakthrough innovations in areas such as molecular medicine, alternative energy, nanotechnology, advanced propulsion and security technologies. GE Global Research is headquartered in Niskayuna, New York and has facilities in Bangalore, India; Shanghai, China, and Munich, Germany.

Genencor International,Rochester, NY:Danisco company, is a leading industrial biotechnology company that develops innovative enzymes and bioproducts to improve the performance and reduce the environmental impact of the cleaning, textiles, fuels and chemicals industries.

Genetest Corporation, Buffalo, NY:Provides DNA paternity testing, Non-invasive prenatal testing, forensic and genetic disease analysis. Identification genetics through Genetest is commonly used to provide DNA evidence for child custody, divorce, support payments, immigration, will estate relation establishment, adoption, legal admission and curiosity purposes.

Genzyme Genetics, NY, NY:A leading, nationwide provider of high quality genetic testing and genetic counseling services for physicians and their patients. With laboratories and counseling facilities located across the U.S., Genzyme Genetics offers extensive reproductive and cancer testing services, supported by innovative technology and a commitment to quality service and trusted information. Genzyme Genetics is a business unit of Genzyme Corporation.Genzyme Corporation is a global biotechnology company dedicated to making a major positive impact on the lives of people with serious diseases.

Histogenetics, Ossington, NY:Provides high and low throughput molecular tissue typing services at low cost. They operate a state-of-the-art R&D and service laboratory, using robotics and bioinformatics technology, and emphasize high quality and fast turnaround time for results. Histogenetics works with both regional and national transplant centers and national and international donor registries,

Hospital for Special Surgery Office, NY, NY: HSS provides orthopedic and rheumatologic patient care at NewYork-Presbyterian Hospital at New York Weill Cornell Medical Center. All HSS medical staff are on the faculty of Weill Medical College of Cornell University. Its Research Institute is internationally recognized as a leader in the investigation of musculoskeletal and autoimmune diseases.

ImClone Systems, NY, NY:Committed to advancing oncology care by developing and commercializing a portfolio of targeted biologic treatments designed to address the medical needs of patients with a variety of cancers. The Company's research and development programs include growth factor blockers and angiogenesis inhibitors. ImClone Systems' strategy is to become a fully integrated biopharmaceutical company, taking its development programs from the research stage to the market. ImClone Systems' headquarters and research operations are located in New York City, with additional administration and manufacturing facilities in Branchburg, New Jersey.

Intra-cellular Therapies, NY, NY: ITI is developing novel therapies for the treatment of Central Nervous System (CNS) disorders. By applying IntraPath, its integrated platform based on technologies developed in the laboratory of Dr. Paul Greengard of the Rockefeller University, ITI is developing drugs for the treatment of neuropsychiatric and neurodegenerative disorders.

Invitrogen, Grand Island, NY:Provides essential life science technologies to academic and government research institutions, and pharmaceutical and biotech companies. The company's own research and development efforts are focused on breakthrough innovation in all major areas of biological discovery including functional genomics, proteomics, bioinformatics and cell biology.

IRX Therapeutics, Inc., , NY, NY:A privately held immunotherapy company focusing on the discovery and commercialization of treatments for advanced cancer and viral diseases. IRX discovers and develops therapeutic treatments that act on multiple cellular targets to restore the immune system's ability to treat those diseases.

Kaken PharmaceuticalL Co., Ltd., can be traced back to the Institute of Physical and Chemical Research ( Riken ), established in 1917. The Company started pharmaceutical business with full-scale development of penicillin and streptomycin based on Riken's own technologies in 1948.
The new headquarters were opened in 1998 in Bunkyo Green Court, an urban community center in Tokyo, Japan, where KAKEN's origin, Riken, started. The Company strives to improve the quality of life of patients through the development and distribution of superior drugs.

Lescarden Inc., NY,NY:A publicly-owned biotechnology company focused on the development of natural biologic therapies for the chronic wound care, dermatology and osteoarthritis markets. Lescarden’s research team, led for many years by one of its founders, Dr. John Prudden, is responsible for the breakthrough studies conducted with bovine cartilage. These efforts brought the Lescarden team to the successful development of Catrix, a product that is recognized for its therapeutically diverse applications, both systemic and topical.

Nanoprobes, Inc., Yaphank, NY:Researches and develops the biomedical and high-technology applications of metal nanoparticles. The company is a leader in immunogold technology, with products which include the 1.4 nm Nanogold® cluster immunoprobes and labeling reagents and the combined fluorescent and gold immunoprobe FluoroNanogold which is used for correlative fluorescence and electron microscopy, and ultrasensitive in situ hybridization detection reagents

Nastech Pharmaceutical Co., Hauppauge, NY:A pharmaceutical company developing innovative products based on proprietary molecular biology-based drug delivery technologies. Nastech and its collaboration partners are developing products for multiple therapeutic areas including inflammatory conditions, obesity and osteoporosis.

OSI Pharmaceuticals, Inc., Melville, NY: developing and commercializing high-quality and novel pharmaceutical products that extend life or improve the quality of life for patients with cancer, eye diseases and diabetes

Pfizer Inc., NY, NY: Discovers, develops, manufactures, and markets leading prescription medicines for humans and animals and many of the world's best-known consumer brands. Our innovative, value-added products improve the quality of life of people around the world and help them enjoy longer, healthier, and more productive lives. The company has three business segments: health care, animal health and consumer health care, and its products are available in more than 150 countries. 

PhV Corporation, NY, NY: A life science business with a platform technology engine
for generating multiple products and delivery systems applicable to the nutraceutical, pharmaceutical, and cosmeceutical markets. PhV’s patented platform technology incorporates nano-engineered molecules and colloids of natural, semi-synthetic and synthetic origin with electro-chemically modified water molecules to produce unique catalytic anti-oxidant/pro-oxidant compounds.

Progenics Pharmaceuticals, Inc., Tarrytown, NY:A biopharmaceutical company focusing on the development and commercialization of innovative therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases. The company's principal programs are directed toward symptom management and supportive care, human immunodeficiency virus, or HIV, infection and cancer. They have five product candidates in clinical development and several others in preclinical development.

PsychoGenics, Tarrytown, NY:Combines expertise in behavioral neurobiology with state-of-the-art technology to produce proprietary, high-throughput behavioral testing platforms that rapidly screens compound libraries for CNS activity. These platforms are being used with PsychoGenics’ established behavioral tests to develop a pipeline of in-house and partnered drug candidates addressing such major CNS disorders as ADHD, anxiety, cognitive impairment, depression, eating disorders, pain, and psychosis/schizophrenia.

Q-RNA Inc., NY, NY: mission is to develop its novel drug target and discovery systems and use them to discover and optimize therapeutics to treat Alzheimer’s disease (AD). With its initial focus on Alzheimer's disease, the Company will begin with a library of anti-amyloid compounds designed by a former founder of Neurochem, Inc. (NRMX) which currently has a compound in Phase II/III testing.

Redox Pharmaceutical Corp, NY, NY:Patented a family of metallo-organic compounds with demonstrated effectiveness in antiviral, antibacterial and anti-inflammatory applications.

Regeneron Pharmaceutical Inc., Tarrytown, NY: A biopharmaceutical company that discovers, develops, and intends to commercialize therapeutic medicines for the treatment of serious medical conditions. Regeneron has therapeutic candidates in clinical trials for the potential treatment of cancer and eye diseases, rheumatoid arthritis and other inflammatory conditions, and asthma and has preclinical programs in other diseases and disorders. Regeneron corporate headquarters are in Tarrytown, NY.

Royalty Pharma, NY, NY: Growing within the biopharmaceutical industry through the acquisition of revenue producing intellectual property principally royalty interests in marketed and late stage development biopharmaceutical products. Royalty Pharma does not discover, develop, manufacture or market products.

SIGA Technologies, NY, NY:Applying viral and bacterial genomics and sophisticated computational modeling in the design and development of novel products for the prevention and treatment of serious infectious diseases, with an emphasis on products for biological warfare defense. SIGA's product development programs emphasize the increasingly serious problem of drug resistant bacteria and emerging pathogens. SIGA's vaccine and drug platforms are based on its pioneering research into the structure, function and processing of bacterial surface proteins. SIGA is leveraging these platforms through multiple strategic partners, including the National Institutes of Health and TransTech Pharma, Inc.

Torreypines Therapeutics, NY, NY: Axonyx develops products and technologies to treat Alzheimer's disease (AD) and other Central Nervous System (CNS) disorders. Axonyx' business strategy is rooted in four core areas: 1) Focused Pipeline of proprietary compounds that fulfill unmet medical needs, 2) Aggressive Growth Strategy that seeks to leverage in- and out-licensing opportunities, 3) Responsive Operational Network of dedicated high performance and experienced service providers and 4) Financial Strength allowing robust product development and pipeline growth.

Trinity Biotech, Jamestown, NY:A public company with manufacturing facilities in Bray-Ireland, Jamestown-NY, Carlsbad-Ca, Lemgo-Germany and Umea-Sweden. The company specialises in the development, manufacture and marketing of diagnostic products for the point-of-care and clinical laboratory segments of the diagnostic market. The broad line of test kits are used to detect infectious diseases, sexually transmitted diseases, blood coagulation disorders, and autoimmune diseases.

United Biomedical Inc., Hauppauge, NY: UBI is a privately held international bio/pharmaceutical company striving to address unmet global needs for disease prevention and treatment with a set of proprietary technologies based on designer peptides and complimentary vaccine delivery systems which has given UBI a product portfolio of high impact immunotherapeutic and vaccine products. UBI’s vaccine technology has already been validated by the successful development and regulatory approval of the first synthetic peptide-based vaccine against the devastating livestock disease, Foot-and-Mouth Disease (FMD). The UBI FMD vaccine has been approved for use as a swine vaccine by the Ministry of Agriculture in China. At UBI, we aim to improve, enhance, and extend health by developing safe, effective, and affordable products.

Vaccinex, Rochester, NY: A biotechnology company engaged in the discovery and development of novel therapeutic antibodies. Using its proprietary vaccinia vector technology, Vaccinex has developed the only library-based antibody discovery technology capable of directly expressing bivalent, fully human antibodies in mammalian cells. Moreover, this technology offers the potential to generate antibodies against difficult targets such as homologous proteins and multi-pass membrane receptors. The company has received more than $10 million in research grants awards and over $20 million in venture funding. Vaccinex is headquartered in Rochester, NY and currently employs 40 scientists and staff. 
 
Warren Pharmaceuticals, Inc., Ossing, NY:A privately held biotech company which develops proprietary tissue-protective technologies. They have identified novel proteins named tissue protective cytokines (TPCs) having potent protective effects that diminish and reverse the underlying cellular damage in these significant diseases, and with safety profiles consistent with treatments requiring acute or long-term administration.

Wyeth, Pearl river, NY:A leading pharmaceutical manufacturing facility in the New York area. In addition to manufacturing the number-one and number-two-selling multivitamins, our vaccines and infectious-disease initiatives are designed to reduce the number of serious illnesses and deaths from bacterial and viral infection and to help overcome the growing problem of bacterial resistance to existing treatments. At the Pearl River Research Center, the company conducts research in therapeutic areas, including oncology, immunology, and infectious diseases.

ZeptoMetrix,  Buffalo, NY:A fully integrated biotechnology company that manufactures and distributes products for the research and biotechnology communities worldwide including state of the art facilities for the development and manufacture of our products are large Biological Level 3 and Level 4 laboratories which are used for the production of HIV, HTLV, CMV and other pathogenic organisms.


Centers, Institutes, Organization, Assoications and Foundations of Biotechnology Industry Related in New York.
AMDeC Foundation, NY, NY:A tax exempt organization under section 501 (c)(3) of the Internal Revenue Code comprised of one member, AMDeC, LLC. The members of AMDeC, LLC include more than thirty healthcare organizations, medical schools, and research institutions within New York State. AMDeC receives grant contributions primarily from governmental entities and corporate foundations. Such contributions fund biomedical and genomics-related research activities and initiatives managed by AMDeC and undertaken collectively by AMDeC-affiliated institutions.

Broad Hollow Bioscience Park,  Farmingdale, NY: Trade Organizations, Biotech Incubators, economic development.

Brookhaven National Laboratory, Upton, NY:A multi-program national laboratory operated by Brookhaven Science Associates for the U.S. Department of Energy. Brookhaven National Laboratory's role for the DOE is to produce excellent science and advanced technology with the cooperation, support, and appropriate involvement of our scientific and local communities.

Center for Biotechnology,  Stony Brook, New York: Established as a cooperative research and development partnership between universities, private industry, and New York State. Its goal has been to capitalize on the resources of New York's medical biotechnology research for the purpose of fuelling economic development in New York State.

Cold Spring Harbor Laboratory, Cold Spring Harbor Laboratory, NY:A private, non-profit basic research institution. Under the leadership of Dr. Bruce Stillman, a member of the National Academy of Sciences and a Fellow of the Royal Society (London), more than 330 scientists at the Laboratory conduct groundbreaking research in cancer, neurobiology, plant genetics, and bioinformatics. Cold Spring Harbor Laboratory is one of eight National Cancer Institute-designated basic research centers in the U.S. and the only such center in the tri-state area.

Council on Biomedical Research and Development at The New York Academy of Medicine, NY, NY:Aa consortium of the leading health science centers in New York City and New York State

Curative Health Services, Hauppauge, NY, NY:Seeks to deliver high-quality care and clinical results for patients with serious or chronic medical conditions. The Specialty Infusion business, through its national footprint of local pharmacy branches, provides products, related clinical services and disease management support to patients with chronic or severe conditions such as hemophilia and other bleeding disorders, chronic or severe infections, gastrointestinal illnesses that prohibit oral digestion and other severe conditions requiring nutritional support, immune system disorders, cancer and susceptibility to respiratory syncytial virus.

Health Research Institute, HRI,  Rensselaer, NY : A not-for-profit corporation affiliated with the New York State Department of Health (DOH) and the Roswell Park Cancer Institute (RPCI) a leading cancer research center located in Buffalo, NY. HRI's mission is to assist DOH and RPCI to effectively evaluate, solicit, and administer external financial support for DOH and RPCI projects, and to disseminate the benefits of DOH expertise through programs such as technology transfer.

ImClone Systems, NY, NY:Committed to advancing oncology care by developing and commercializing a portfolio of targeted biologic treatments designed to address the medical needs of patients with a variety of cancers. The Company's research and development programs include growth factor blockers and angiogenesis inhibitors. ImClone Systems' strategy is to become a fully integrated biopharmaceutical company, taking its development programs from the research stage to the market. ImClone Systems' headquarters and research operations are located in New York City, with additional administration and manufacturing facilities in Branchburg, New Jersey.

Memorial Sloan-Kettering Cancer Ctr., NY,NY: The OIA is responsible for protecting and licensing inventions developed by MSKC Center investigators, obtaining industrial funding for laboratories, and negotiating and reviewing private consulting agreements.

Mount Sinai School of Medicine, Office of Industrial Liaison, Ny, NY:The OIL's mission is to increase relationships between MSSM and industry and to create a synergistic culture of commercial exploitation of MSSM innovation, consistent with the public good and traditional concerns for academic freedom and independence.

New York Academy of Sciences, NY, NY: The New York Academy of Sciences has been bringing together scientists of different disciplines from around the world. Their purpose is to advance the understanding of science, technology, and medicine, and to stimulate new ways to think about how their research is applied in society and the world.

New York Biotechnology Association, Stony Brook, NY:A not-for-profit trade association dedicated to the development and growth of New York State based biotechnology related industries and institutions, and to strengthening the competitiveness of New York State as a premier global location for biotechnology/biomedical research, education and industry.

North Shore Long Is. Jewish Research Inst., Manhasset, NY: The mission of the Office of Research Compliance (ORC) is the development of a Research Compliance Program that includes distribution of written policies, procedures and standards of conduct that promote adherence to applicable federal and New York State laws and institutional policies.

Rockefeller Foundation, NY,NY: The Foundation works to expand opportunities for the poor by providing grants to help eradicate poverty and hunger, minimize the burden of disease, improve employment opportunities, increase the availability and quality of housing and schools, and encourage artistic and cultural expression.

Hunter College of CUNY, Ny,NY: The Office of Research Administration provides information relating to grants and contracts for project support. The office's main functions involve the review, institutional approval, and submission of proposals to government and private agencies, the interpretation of Research Foundation policies, the review of all grant-funded personnel appointments, and the dissemination of information on grant opportunities.

Monroe Community College, Rochester, NY: The Biotechnology career program is recommended for individuals with a strong interest in biology, biochemistry, and molecular genetics. Emphasis is on the bioanalytical techniques and instrumentation that are basic to understanding the application of biological systems to the field of biotechnology. Graduates of this program may be employed in universities, pharmaceutical companies, food processing industries, and a variety of industrial laboratories engaged in research and development of genetically engineered products. Students who are not seeking immediate employment have the option of transferring to a four-year institution to pursue an advanced degree.

New York Medical College, NY,NY: Technology Development initiates, negotiates and manages research relationships with industry and the transfer of research results to commercial application. The objective is to make the College's research available for public use and benefit and to generate new revenue streams to support research.

Rensselaer Polytechnic Institute, Troy, NY:The nation’s oldest technological university. The university offers bachelor’s, master’s, and doctoral degrees in engineering, the sciences, information technology, architecture, management, and the humanities and social sciences

Rochester Institute of Technology, Rochester, NY:Created the Center for Biotechnology Education and Training (CBET), dedicated to supporting a growing and dynamic biotechnology industry.

Rockefeller University, NY, NY: The OTT promotes and supports the research enterprise at the University by creating relationships with the private sector to develop, protect, transfer and commercialize research results for the public benefit.